Market Cap 513.82M
Revenue (ttm) 0.00
Net Income (ttm) -156.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.73
Volume 942,900
Avg Vol 3,876,690
Day's Range N/A - N/A
Shares Out 68.06M
Stochastic %K 43%
Beta 2.32
Analysts Sell
Price Target $33.67

Company Profile

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company's lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 676 5000
Address:
The Omeros Building, 201 Elliott Avenue West, Seattle, United States
Iceman89
Iceman89 Oct. 28 at 12:15 AM
$OMER I learned something new today - FDAs voluntary Postmarketing commitment (pmc) vs mandatory Postmarketing requirement (pmr) (phase 4) for post approval. I would guess that voluntary PMC would be enough for Narsoplimab and the collected RWE (real world evidence) data could be basis for label expansion later. Even if the FDA requires mandatory phase 4, then the company has enough funds for that. Phase 4 is more likely used when surrogate endpoints were used for approval, which is not the case here.
1 · Reply
Niuniucat
Niuniucat Oct. 27 at 10:13 PM
$OMER why volume keeps going down?
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 8:56 PM
Enter: $OMER Calls Strike Price: $8 Expiry Date: NOV 21 2025 Buy in Price: $0.79 - $0.83 Sell Price: $1.60 Profit : +102% (Turn every $1 into $2.02) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
arodtx
arodtx Oct. 27 at 8:54 PM
$OMER https://www.targetedonc.com/view/new-evidence-emerges-on-narsoplimab-s-therapeutic-potential-in-ta-tma
1 · Reply
MinnieSteve3
MinnieSteve3 Oct. 27 at 8:45 PM
$OMER Nice to see some green today. Interestingly, since the 125 million share trading volume on Oct 15, the day the Novo deal was announced, trading volume has decreased every day since for 8 consecutive days.
1 · Reply
Sasquamch
Sasquamch Oct. 27 at 8:42 PM
$OMER talking now about NVO purchases and other bio stock buyouts. again, they didnt buy uou out
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 8:27 PM
$OMER watch SMCI and learn something
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 7:48 PM
$OMER what a day!!! new all time highs
0 · Reply
arodtx
arodtx Oct. 27 at 7:08 PM
$OMER falling wedge pattern 🤔
2 · Reply
Niuniucat
Niuniucat Oct. 27 at 6:04 PM
$OMER added.
1 · Reply
Latest News on OMER
Omeros Corporation (OMER) Q2 2025 Earnings Call Transcript

Aug 19, 2025, 4:41 PM EDT - 2 months ago

Omeros Corporation (OMER) Q2 2025 Earnings Call Transcript


Omeros Corporation Reports Second Quarter 2025 Financial Results

Aug 14, 2025, 4:02 PM EDT - 2 months ago

Omeros Corporation Reports Second Quarter 2025 Financial Results


Omeros Corporation Reports First Quarter 2025 Financial Results

May 15, 2025, 4:05 PM EDT - 5 months ago

Omeros Corporation Reports First Quarter 2025 Financial Results


Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight

Apr 11, 2025, 3:06 PM EDT - 7 months ago

Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight


Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:57 PM EDT - 7 months ago

Omeros Corporation (OMER) Q4 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:22 PM EST - 1 year ago

Omeros Corporation (OMER) Q3 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 1:05 AM EDT - 1 year ago

Omeros Corporation (OMER) Q2 2024 Earnings Call Transcript


Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript

May 15, 2024, 7:23 PM EDT - 1 year ago

Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript


Iceman89
Iceman89 Oct. 28 at 12:15 AM
$OMER I learned something new today - FDAs voluntary Postmarketing commitment (pmc) vs mandatory Postmarketing requirement (pmr) (phase 4) for post approval. I would guess that voluntary PMC would be enough for Narsoplimab and the collected RWE (real world evidence) data could be basis for label expansion later. Even if the FDA requires mandatory phase 4, then the company has enough funds for that. Phase 4 is more likely used when surrogate endpoints were used for approval, which is not the case here.
1 · Reply
Niuniucat
Niuniucat Oct. 27 at 10:13 PM
$OMER why volume keeps going down?
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 27 at 8:56 PM
Enter: $OMER Calls Strike Price: $8 Expiry Date: NOV 21 2025 Buy in Price: $0.79 - $0.83 Sell Price: $1.60 Profit : +102% (Turn every $1 into $2.02) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
arodtx
arodtx Oct. 27 at 8:54 PM
$OMER https://www.targetedonc.com/view/new-evidence-emerges-on-narsoplimab-s-therapeutic-potential-in-ta-tma
1 · Reply
MinnieSteve3
MinnieSteve3 Oct. 27 at 8:45 PM
$OMER Nice to see some green today. Interestingly, since the 125 million share trading volume on Oct 15, the day the Novo deal was announced, trading volume has decreased every day since for 8 consecutive days.
1 · Reply
Sasquamch
Sasquamch Oct. 27 at 8:42 PM
$OMER talking now about NVO purchases and other bio stock buyouts. again, they didnt buy uou out
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 8:27 PM
$OMER watch SMCI and learn something
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 7:48 PM
$OMER what a day!!! new all time highs
0 · Reply
arodtx
arodtx Oct. 27 at 7:08 PM
$OMER falling wedge pattern 🤔
2 · Reply
Niuniucat
Niuniucat Oct. 27 at 6:04 PM
$OMER added.
1 · Reply
in_GOD_alone
in_GOD_alone Oct. 27 at 6:04 PM
$OMER Holy horse. We green?
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 5:41 PM
$OMER target price $28?? give me a break lol
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 4:14 PM
$OMER Simple, just as i said. you are not approved. this entire deal from NVO is not done deal. Shorts know it and will tank to $4.50
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 4:07 PM
$OMER oh my god NVO bought RNA. they didnt want to buy OMER LMAO
1 · Reply
arodtx
arodtx Oct. 27 at 3:34 PM
0 · Reply
Option_trader11
Option_trader11 Oct. 27 at 3:01 PM
$OMER it just took a pause 🙄🙄🙄
0 · Reply
in_GOD_alone
in_GOD_alone Oct. 27 at 2:35 PM
$OMER I will give up sex for a year once we hit $15.
8 · Reply
MinnieSteve3
MinnieSteve3 Oct. 27 at 2:24 PM
$OMER MM's continue to toy with this stock. Oh well, news is forthcoming.
0 · Reply
AVCTQBNAPL
AVCTQBNAPL Oct. 27 at 1:44 PM
$OMER 🗣️🗣️🗣️🗣️🤩🎉🥳🥂🍾👇👇👇👇🫡 https://finance.yahoo.com/news/omeros-corporation-omer-one-hot-100550939.html
0 · Reply
Max1962
Max1962 Oct. 27 at 1:42 PM
$OMER look at arrowhead pharma deal last September. We got more up front money, higher milestones, higher peak royalties. They have $5 bb market cap.
2 · Reply
Sasquamch
Sasquamch Oct. 27 at 12:40 PM
$OMER wont be around here cheering you on today. making too much money elsewhere!!!
0 · Reply
Sasquamch
Sasquamch Oct. 27 at 11:56 AM
$OMER market looks hot this morning. wont help here but i will make money and add if red here
0 · Reply